Executive record

Timothy Schroeder

Director at Inmune Bio, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:timothy-schroederVersion: public-0As of: 2026-09-30

Not yet claimed12 published Claims4 sources
  • Director

Key Claims

Biography

Chairman, CEO and Founder of CTI Clinical Trial Consulting Services since 1999, a multi-national research firm supporting over 200 drug and device approvals. Over 35 years of clinical, academic, and industry experience in global drug and device development programs.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2026 to end not publishedExecutive title: Independent Director · Organization not publishedINMB DEF 14A executive officers
  2. Dates not publishedExecutive title: Chairman, CEO and Founder · Organization not publishedINMB DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. INMB DEF 14A director slate

    sec filing · Source published: Apr 23, 2026 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Compensation · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at CTI Clinical Trial & Consulting Services · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chairman, CEO and Founder · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. INMB DEF 14A executive officers

    sec filing · Source published: Apr 23, 2026 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Inmune Bio, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Independent Director · Claim reviewed: May 16, 2026
    • Other Company Role: Timothy Schroeder is also linked to CTI Clinical Trial Consulting Services as Chairman, CEO and Founder. · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  3. Open source

    sec proxy · Source published: Apr 23, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Inmune Bio, Inc. · Claim reviewed: May 16, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Inmune Bio, Inc. · Claim reviewed: May 16, 2026